Add to ORKGMulticenter controlled trial in patients (PTS) with epithelial ovarian cancer (OC) Stage I
<p><b>A)</b> Stages IA/B, IC, and II. <b>B)</b> Different histological types. <b>C)</b> Taxane- and ...
A prospective, non-randomized, multicentre, open, dose-finding study of a carboplatin-docetaxel (C-D...
BACKGROUND: Adjuvant platinum-based chemotherapy improves survival in women with early-stage epithel...
The question of whether platinum-based adjuvant chemotherapy can improve outcomes in patients with e...
<p>Epithelial ovarian cancer (EOC) patient cohorts for the development and validation of integrated ...
Objective To review the incidence of Stage I epithelial ovarian carcinoma in the West Midlands regio...
Martin K. Oehler is a member of the Australian Ovarian Cancer Study Group and the Patterns of Care ...
The North West Oncology Group is a cooperative group that has carried out several clinical trials on...
Epithelial ovarian cancers (EOCs) are, although still treated as a single disease entity, often clas...
Objective: Despite results from Gynecologic Oncology Group (GOG) 157 showing no statistically signif...
Epithelial ovarian cancer generally presents at an advanced stage and is the most common cause of gy...
Abstract Ovarian cancer is the most lethal gynecologic malignancy. It appears that the vast majority...
Objective. The aim of this study was to document the survival advantage of lowering stage at detecti...
Objectives GEN-1, an IL-12 DNA plasmid formulated with a synthetic carrier is being evaluated with n...
PURPOSE: Although ovarian cancer is one of the most chemotherapy-sensitive solid tumors, cure after ...
<p><b>A)</b> Stages IA/B, IC, and II. <b>B)</b> Different histological types. <b>C)</b> Taxane- and ...
A prospective, non-randomized, multicentre, open, dose-finding study of a carboplatin-docetaxel (C-D...
BACKGROUND: Adjuvant platinum-based chemotherapy improves survival in women with early-stage epithel...
The question of whether platinum-based adjuvant chemotherapy can improve outcomes in patients with e...
<p>Epithelial ovarian cancer (EOC) patient cohorts for the development and validation of integrated ...
Objective To review the incidence of Stage I epithelial ovarian carcinoma in the West Midlands regio...
Martin K. Oehler is a member of the Australian Ovarian Cancer Study Group and the Patterns of Care ...
The North West Oncology Group is a cooperative group that has carried out several clinical trials on...
Epithelial ovarian cancers (EOCs) are, although still treated as a single disease entity, often clas...
Objective: Despite results from Gynecologic Oncology Group (GOG) 157 showing no statistically signif...
Epithelial ovarian cancer generally presents at an advanced stage and is the most common cause of gy...
Abstract Ovarian cancer is the most lethal gynecologic malignancy. It appears that the vast majority...
Objective. The aim of this study was to document the survival advantage of lowering stage at detecti...
Objectives GEN-1, an IL-12 DNA plasmid formulated with a synthetic carrier is being evaluated with n...
PURPOSE: Although ovarian cancer is one of the most chemotherapy-sensitive solid tumors, cure after ...
<p><b>A)</b> Stages IA/B, IC, and II. <b>B)</b> Different histological types. <b>C)</b> Taxane- and ...
A prospective, non-randomized, multicentre, open, dose-finding study of a carboplatin-docetaxel (C-D...
BACKGROUND: Adjuvant platinum-based chemotherapy improves survival in women with early-stage epithel...